Breaking News

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
DLPH Delphi Technologies $15.67 0.87 (5.88%) , CREE Cree $45.86 2.29 (5.26%) 06:35 09/09/19 09/09 06:35 09/09/19 06:35 Hot Stocks	Delphi Technologies, Cree partner on automotive silicon carbide devices » Delphi Technologies… Delphi Technologies (DLPH) and Cree (CREE) announce a partnership to utilize silicon carbide semiconductor device technology to enable faster, smaller, lighter and more powerful electronic systems for future electric vehicles. Cree's silicon carbide-based MOSFET technology coupled with Delphi Technologies' traction drive inverters, DC/DC converters and chargers will extend driving range and deliver faster charging times of EVs, while also lowering weight, conserving space and reducing cost. The Cree silicon carbide MOSFETs will initially be used in Delphi Technologies' 800 Volt inverters for a premium global automaker. Production will ramp in 2022. DLPH Delphi Technologies $15.67 0.87 (5.88%) CREE Cree $45.86 2.29 (5.26%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Sep 11 Sep 30 Oct
NXPI NXP Semiconductors $102.90 2.61 (2.60%) , EXPO Exponent $70.36 -0.14 (-0.20%) … 10:18 08/29/19 08/29 10:18 08/29/19 10:18 Initiation	Fly Intel: Top five analyst initiations » Catch up on today's… Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. NXP Semiconductors (NXPI) initiated with a Buy at Loop Capital. 2. Exponent (EXPO) initiated with a Neutral at DA Davidson. 3. Dova Pharmaceuticals (DOVA) initiated with an Outperform at Oppenheimer. 4. Cree (CREE) initiated with an Underperform at Exane BNP Paribas. 5. MarketAxess (MKTX) initiated with a Hold at Argus. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here. NXPI NXP Semiconductors $102.90 2.61 (2.60%) EXPO Exponent $70.36 -0.14 (-0.20%) DOVA Dova Pharmaceuticals $15.63 0.46 (3.03%) CREE Cree $44.62 0.74 (1.69%) MKTX MarketAxess $401.51 -2.81 (-0.69%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	04 Sep 10 Sep 19 Sep 17 Oct 30 Oct
CREE Cree $43.88 0.01 (0.02%) 09:33 08/29/19 08/29 09:33 08/29/19 09:33 Initiation	Cree initiated at Exane BNP Paribas » Cree initiated with an… Cree initiated with an Underperform at Exane BNP Paribas. Exane BNP Paribas initiated Cree with an Underperform and $40 price target. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	30 Oct
VZ Verizon $57.25 0.63 (1.11%) , WW WW $30.04 1.16 (4.02%) … 10:17 08/27/19 08/27 10:17 08/27/19 10:17 Upgrade	Fly Intel: Top five analyst upgrades » Catch up on today's… Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Outperform from Perform at Oppenheimer with analyst Timothy Horan saying he believes both Verizon and AT&T (T) will benefit from elevated T-Mobile (TMUS)/Sprint (S) churn from the new company. 2. WW (WW) upgraded to Buy from Hold at Craig-Hallum with analyst Alex Fuhrman saying he sees "improving trends" for the company with the positive reception of its Kurbo By WW launch and the upside potential of its new upcoming diet program launch. 3. Cree (CREE) upgraded to Neutral from Underweight at JPMorgan with analyst Paul Coster citing valuation. 4. MongoDB (MDB) upgraded to Buy from Neutral at Citi with analyst Tyler Radke saying the shares have lagged high-growth peers the last six months on concerns around sustainability of growth. 5. Exelon (EXC) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Stephen Byrd saying after backing out the utility, Exelon's shares price in no value for its 32 GW unregulated merchant fleet, which generates "strong" free cash flow. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. VZ Verizon $57.25 0.63 (1.11%) WW WW $30.04 1.16 (4.02%) CREE Cree $44.69 1.512 (3.50%) MDB MongoDB $156.55 9.97 (6.80%) EXC Exelon $46.76 1.095 (2.40%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	04 Sep 10 Sep 13 Sep 02 Oct 30 Oct 10 Nov
CREE Cree $43.18 -3.89 (-8.26%) 07:09 08/27/19 08/27 07:09 08/27/19 07:09 Upgrade	JPMorgan upgrades Cree to Neutral after 26% post-earnings selloff » JPMorgan analyst Paul… JPMorgan analyst Paul Coster upgraded Cree to Neutral from Underweight with an unchanged price target of $45. The shares have fallen 26% since the company's "lackluster" fiscal Q4 results on August 20, Coster tells investors in a research note. The analyst believes Cree is now trading close to fair value. The risks are balanced, and the stock should trade in line with peers over the next 6-12 months, Coster contends. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	30 Oct

CREE Cree $43.18 -3.89 (-8.26%) 04:49 08/27/19 08/27 04:49 08/27/19 04:49 Upgrade	Cree rating change at JPMorgan » Cree upgraded to Neutral… Cree upgraded to Neutral from Underweight at JPMorgan. JPMorgan analyst Paul Coster upgraded Cree to Neutral from Underweight with an unchanged price target of $45. The analyst cites valuation for the upgrade following the recent pullback in the shares. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	30 Oct
AMGN Amgen $205.02 5.91 (2.97%) , CELG Celgene $96.69 2.69 (2.86%) … 16:20 08/26/19 08/26 16:20 08/26/19 16:20 On The Fly	Fly Intel: Wall Street's top stories for Monday » Stocks closed broadly… Open Full Text AMGN Amgen $205.02 5.91 (2.97%) CELG Celgene $96.69 2.69 (2.86%) BMY Bristol-Myers $48.02 1.43 (3.07%) JNJ Johnson & Johnson $127.68 0.84 (0.66%) FTI TechnipFMC $24.08 0.99 (4.29%) ORCL Oracle $52.08 0.5 (0.97%) PDCE PDC Energy $29.35 4.08 (16.15%) SRCI SRC Energy $4.61 0.455 (10.95%) AKRX Akorn $3.02 0.32 (11.85%) ZGNX Zogenix $46.15 -3.92 (-7.83%) CREE Cree $43.47 -3.6 (-7.65%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Aug 26 Aug 26 Aug 26 Aug 26 Aug 27 Aug 03 Sep 04 Sep 09 Sep 11 Sep 12 Sep 16 Sep 19 Sep 19 Sep 01 Oct 15 Oct 30 Oct 04 Dec 25 Mar 04 Apr
DISH Dish $32.15 1.08 (3.48%) , LYFT Lyft $50.58 1.5 (3.06%) … 10:57 08/26/19 08/26 10:57 08/26/19 10:57 On The Fly	Dish double upgrade, Foot Locker downgrades among today's top analyst actions » Check out today's top… Open Full Text DISH Dish $32.15 1.08 (3.48%) LYFT Lyft $50.58 1.5 (3.06%) UBER Uber $33.13 -0.3 (-0.90%) FL Foot Locker $34.85 0.85 (2.50%) CREE Cree $45.08 -1.99 (-4.23%) NFLX Netflix $293.90 2.5 (0.86%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Sep 19 Sep 23 Sep 25 Sep 30 Oct 22 Nov
FL Foot Locker $33.78 -0.22 (-0.65%) , STLD Steel Dynamics $26.53 -0.02 (-0.08%) … 10:07 08/26/19 08/26 10:07 08/26/19 10:07 Downgrade	Fly Intel: Top five analyst downgrades » Catch up on today's… Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Foot Locker (FL) downgraded to Neutral from Outperform at Baird and to Neutral from Positive at Susquehanna. 2. Steel Dynamics (STLD) downgraded to Neutral from Buy at Longbow with analyst Christopher Olin saying his confidence in the Steel Mill segment's ability to meet or beat expectations in the second half of 2019 is eroding. 3. Abraxas Petroleum (AXAS) downgraded to Neutral from Buy at Ladenburg with analyst Michael Schmitz saying reduced estimated free cash flow resulting from lower projected commodity prices, combined with uncertainty resulting from the escalation of the trade war, will be additional headwinds for the Exploration and Production group. 4. Elanco (ELAN) downgraded to Neutral from Buy at BofA/Merrill with analyst Michael Ryskin saying while the acquisition of Bayer's (BAYRY) Animal Health business could turn out positive in the longer term, there is too much uncertainty in the near-term, including which parts of the portfolio will be divested due to antitrust issues. 5. Cree (CREE) downgraded to Underweight from Neutral at Piper Jaffray with analyst Harsh Kumar reducing his estimates reducing to reflect broader weakness in the LED market and the impact of Huawei on the Cree's Wolfspeed business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. FL Foot Locker $33.78 -0.22 (-0.65%) STLD Steel Dynamics $26.53 -0.02 (-0.08%) AXAS Abraxas Petroleum $0.51 0.0086 (1.72%) ELAN Elanco $26.19 -0.23 (-0.87%) CREE Cree $45.85 -1.22 (-2.59%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Sep 11 Sep 19 Sep 25 Sep 30 Oct 22 Nov
PBI Pitney Bowes $3.61 -0.035 (-0.96%) , MDCO The Medicines Co. $35.05 -0.82 (-2.29%) … 09:00 08/26/19 08/26 09:00 08/26/19 09:00 Hot Stocks	Fly Intel: Pre-market Movers » HIGHER: Pitney Bowes… HIGHER: Pitney Bowes (PBI), up 12% after entering into a definitive agreement to sell its Software Solutions business to Syncsort for $700M in cash and issuing FY19 guidance... The Medicines Co. (MDCO), up 11% after announcing the ORION-11 Phase 3 study of inclisiran sodium 300 mg met all primary and secondary endpoints with efficacy consistent with findings from Phase 1 and 2 studies... Arcadia Biosciences (RKDA), up 23% after announcing Matthew Plavan as its next CEO and providing FY20 revenue guidance... SRC Energy (SRCI), up 3% after entering into a definitive merger agreement under which PDC Energy (PDCE) will acquire the company in an all-stock transaction valued at approximately $1.7B. UP AFTER EARNINGS: Brainsway (BWAY), up 2%. LOWER: Amgen (AMGN), down 2% after entering into an agreement with Celgene (CELG) in connection with its previously announced merger with Bristol-Myers (BMY) to acquire worldwide rights to Otezla for $13.4B in cash... Cree (CREE), down 2% after Piper Jaffray analyst Harsh Kumar downgraded the stock to Underweight from Neutral and cut his price target for the shares to $38 from $57. The analyst reduced his estimates reducing to reflect broader weakness in the LED market and the impact of Huawei on the Cree's Wolfspeed business. PBI Pitney Bowes $3.61 -0.035 (-0.96%) MDCO The Medicines Co. $35.05 -0.82 (-2.29%) RKDA Arcadia Biosciences $6.57 0.01 (0.15%) SRCI SRC Energy $4.16 -0.035 (-0.84%) BWAY Brainsway $10.65 0.65 (6.50%) AMGN Amgen $199.11 -4.32 (-2.12%) CREE Cree $47.07 -0.71 (-1.49%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Aug 26 Aug 31 Aug 02 Sep 09 Sep 16 Sep 19 Sep 30 Oct

On The Fly

News and insights, exclusive to thefly.com

20:25	Notable companies reporting before tomorrow's open»
18:54	Fly Intel: After Hours Movers»
14:23	Notable companies reporting before tomorrow's open»
14:21	Notable companies reporting after market close»
12:30	Juul tells Bloomberg products not available on China websites»

View all On The Fly Stories »

Upcoming
Events (10)

Today	NVST	Envista - NVST
Today	FOLD ...	2019 PDA / FDA Joint Regulatory Conference
Today		Phoenix Multi-Asset Tour
Today	DISCA ...	28th Annual Communacopia Conference
Today		Software Bus Tour 2019
Today		Toys & Media Bus Tour
Today	CSCO	U.S. All Stars Conference
Today		2019 ASTRO Annual Meeting
Today		Big Five Investor Conference
Today	CBSH ...	KC Regional Bank Trip

View all of today’s events »

Today’s
Syndicate (3)

KHC	Block Trade
FNKO	Spot Secondary
SHOP	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial